At the Financial Street Forum, experts highlighted how patient capital is fueling a new wave of humanoid robots in the Chinese mainland 🤖. By betting on long-term growth, investors are fueling innovation from R&D labs to commercial deployment.
One standout player is Galbot, which has pushed the boundaries of embodied AI, bringing robots closer to humanlike movement and interaction. These advances are built on the back of the AI+ initiative and priorities set by the 15th Five-Year Plan, providing clear roadmaps for startups and big tech alike.
Morgan Stanley chief China economist Robin Xing noted that the Chinese mainland now boasts a full AI ecosystem 🌱, spanning hardware, software, and infrastructure. This ecosystem, supported by steady funding, is helping local companies scale up production and enter global markets with confidence.
For young professionals and global investors, the message is clear: patient capital in the Chinese mainland is more than a funding strategy—it’s a launchpad for tomorrow’s tech leaders 🚀. Whether you are an entrepreneur seeking partnerships or a student exploring AI trends, keep an eye on these developments that are shaping a more self-reliant tech future.
Reference(s):
Financial Street Forum: Patient capital fuels China humanoid robots
cgtn.com
